GPT Healthcare Ltd (GPTHEALTH) Q3FY25 Concall Summary - Dec-2024 Qtr
Performance Overview
- GPT Healthcare reported Q3 FY25 revenue of INR 102 crores, a 6% YoY increase.
- Profit after tax (PAT) for Q3 FY25 also rose by 6% YoY to INR 12 crores.
- Nine-month PAT reached INR 37 crores, marking a 5.7% YoY growth.
- EBITDA margin for nine months improved slightly by 2% to 22%, reaching INR 69.6 crores.
- Finance costs decreased by 55% due to debt reduction.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.